SCHEMBL6777584

SCHEMBL6777584

CCCc1nn(-c2cccc(OC)c2)c2c1C(=O)CCC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPT P10636 1/20 0.53
LMNA P02545 3/20 0.49
HTT P42858 2/20 0.49
TSHR P16473 1/20 0.49
SRC P12931 1/20 0.48
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
BRD4 O60885 1/20 0.42
DCTPP1 Q9H773 1/20 0.41
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
USP2 O75604 1/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771081 0.86 ALDH1A1 (0.58) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6769419 0.86 SRC (0.47) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6770366 0.85 SRC (0.56) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6162867 0.85 ALDH1A1 (0.49) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6766537 0.83 ALDH1A1 (0.41) ALDH1A1MAPTLMNAHTTABCG2
SCHEMBL6770581 0.83 ALDH1A1 (0.62) ALDH1A1LMNACA1TP53KMT2A
SCHEMBL6778055 0.81 SRC (0.43) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6766574 0.80 ALDH1A1 (0.39) ALDH1A1MAPTLMNAHTTDCTPP1
SCHEMBL6771294 0.80 SRC (0.49) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL6772956 0.80 SRC (0.49) ALDH1A1MAPTLMNAHTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed